COMMUNIQUÉ DE PRESSE publié le 09/08/2023 à 14:30, il y a 2 années 3 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 08/08/2023 à 14:30, il y a 2 années 3 mois Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 14:30, il y a 2 années 3 mois Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
COMMUNIQUÉ DE PRESSE publié le 03/08/2023 à 14:30, il y a 2 années 4 mois Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
COMMUNIQUÉ DE PRESSE publié le 02/08/2023 à 14:30, il y a 2 années 4 mois REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
COMMUNIQUÉ DE PRESSE publié le 01/08/2023 à 14:40, il y a 2 années 4 mois Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
COMMUNIQUÉ DE PRESSE publié le 27/07/2023 à 14:30, il y a 2 années 4 mois In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
COMMUNIQUÉ DE PRESSE publié le 26/07/2023 à 14:30, il y a 2 années 4 mois Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 25/07/2023 à 14:30, il y a 2 années 4 mois Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton"
COMMUNIQUÉ DE PRESSE publié le 07/07/2023 à 22:15, il y a 2 années 4 mois Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders
Publié le 05/12/2025 à 17:18, il y a 2 heures 5 minutes La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Publié le 05/12/2025 à 17:18, il y a 2 heures 5 minutes The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Publié le 05/12/2025 à 15:10, il y a 4 heures 12 minutes Mersen: Number of shares and voting rights as of November 30, 2025
Publié le 05/12/2025 à 15:10, il y a 4 heures 12 minutes Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Publié le 05/12/2025 à 13:58, il y a 5 heures 25 minutes RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Publié le 05/12/2025 à 19:20, il y a 3 minutes The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Publié le 05/12/2025 à 18:45, il y a 38 minutes Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Publié le 05/12/2025 à 18:20, il y a 1 heure 3 minutes NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Publié le 05/12/2025 à 18:00, il y a 1 heure 23 minutes SMX: A New Supply Chain Reality in the World's Four Largest Markets
Publié le 05/12/2025 à 17:15, il y a 2 heures 8 minutes TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Publié le 05/12/2025 à 18:58, il y a 25 minutes EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Publié le 05/12/2025 à 18:15, il y a 1 heure 8 minutes Completion of merger to form Helvetia Baloise Holding Ltd
Publié le 05/12/2025 à 17:46, il y a 1 heure 37 minutes Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
